{"gene":"PF3D7_0307400","run_date":"2026-09-07T10:55:51","timeline":{"discoveries":[{"year":2010,"finding":"PfClpP (PF3D7_0307400) localizes to the apicoplast of P. falciparum, confirmed by GFP-targeting, immunoelectron microscopy, and immunofluorescence assays. It possesses serine protease activity demonstrated by an in vitro protease assay, and a specific β-lactone inhibitor (U1-lactone) that binds its active site inhibited parasite growth and caused apicoplast developmental defects.","method":"GFP-targeting, immunoelectron microscopy, immunofluorescence assay, in vitro protease assay with active-site β-lactone inhibitor","journal":"Molecular microbiology","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal localization methods plus in vitro enzymatic activity assay with a specific active-site inhibitor, functional consequence demonstrated","pmids":["20545854"],"is_preprint":false,"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2010,"finding":"PfClpP (PF3D7_0307400) forms mostly homoheptameric rings as shown by size-exclusion chromatography, analytical ultracentrifugation, and electron microscopy. Its X-ray crystal structure reveals a compacted tetradecamer (two stacked heptameric rings) similar to Streptococcus pneumoniae and Mycobacterium tuberculosis ClpPs. The protein localizes to the apicoplast.","method":"Size-exclusion chromatography, analytical ultracentrifugation, electron microscopy, X-ray crystallography","journal":"Journal of molecular biology","confidence":"High","confidence_rationale":"Tier 1 / Strong — crystal structure determined plus multiple biophysical methods confirming oligomeric state, replicated across publications","pmids":["20887733"],"is_preprint":false,"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2010,"finding":"The compact tetradecameric conformation of PfClpP observed by X-ray crystallography corresponds to an inactive state; structural and normal mode analysis support a model in which the ClpP cylinder switches dynamically between an active extended state (substrate degradation) and an inactive compact state (peptide product release).","method":"X-ray crystallography of disulfide-linked E. coli ClpP mutant compared with PfClpP structure; normal mode analysis","journal":"Structure","confidence":"Medium","confidence_rationale":"Tier 1 / Weak — crystal structures compared across species and computational modeling used; direct conformational switching not experimentally demonstrated in PfClpP itself","pmids":["20637416"],"is_preprint":false,"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2017,"finding":"Using a double-conditional mutant parasite line, PfClpC chaperone activity was shown to be required to stabilize the mature PfClpP (PF3D7_0307400) protease, revealing a functional chaperone-protease interaction. Conditional inhibition of PfClpP, like PfClpC, led to growth arrest and apicoplast loss rescued by IPP supplementation.","method":"Conditional mutant parasite lines (double-conditional mutant), IPP rescue assay, Western blot for protein stability","journal":"Cell reports","confidence":"High","confidence_rationale":"Tier 2 / Moderate — genetic conditional mutants with orthogonal rescue experiment demonstrating functional interaction; single lab","pmids":["29141210"],"is_preprint":false,"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2020,"finding":"PfClpP (PF3D7_0307400) has robust catalytic activity essential for apicoplast biogenesis. CRISPR/Cas9-expressed catalytically dead PfClpP showed it oligomerizes as a zymogen and is matured via transautocatalysis. Affinity purification screens identified the Clp complex composition and putative ClpP substrates, including an interaction with the PfClpS substrate-adaptor (shown to be essential for plastid biogenesis by conditional mutant) and PfClpC chaperone.","method":"Null and conditional mutants, CRISPR/Cas9-based catalytically dead mutant expression, affinity purification/mass spectrometry","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — catalytic dead mutant with reconstitution-level mutagenesis, CRISPR/Cas9, affinity purification, multiple orthogonal methods in one study","pmids":["32482878"],"is_preprint":false,"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2012,"finding":"Biochemical and structural data indicate that, contrary to what has been observed in other organisms, PfClpP (PF3D7_0307400) and PfClpR do NOT form a stable heterocomplex in the apicoplast of P. falciparum. PfClpR localizes to the apicoplast as does PfClpP, but forms a distinct open flat heptameric ring with an inactive catalytic triad.","method":"X-ray crystallography of PfClpR, biochemical interaction assays, localization by immunofluorescence","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 1–2 / Moderate — crystal structure plus biochemical interaction assays, single lab; the negative result (no stable heterocomplex) is directly relevant to PfClpP function","pmids":["23192353"],"is_preprint":false,"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2017,"finding":"Novel pyrimidine-series compounds identified by in silico structure-based screening inhibit PfClpP (PF3D7_0307400) protease activity in vitro and show antiparasitic activity in blood-stage P. falciparum, with treated parasites exhibiting morphological abnormalities and impaired apicoplast development.","method":"In silico structure-based screening, in vitro PfClpP enzymatic inhibition assay, blood-stage parasite growth assay, morphological analysis","journal":"Bioorganic & medicinal chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vitro enzymatic assay plus cellular phenotypic readout; structure-activity relationship established, single lab","pmids":["28917450"],"is_preprint":false,"attribution":[{"species":"Plasmodium falciparum","strain":""}]}],"current_model":"PF3D7_0307400 (PfClpP) is an apicoplast-localized serine protease that assembles as a homoheptameric ring (and tetradecamer) via transautocatalytic zymogen maturation, requires the PfClpC chaperone for its stability and activity, participates in a Clp proteolytic complex with PfClpC and the substrate-adaptor PfClpS (but does not form a stable heterocomplex with PfClpR), and is essential for apicoplast biogenesis and parasite survival."},"narrative":{"mechanistic_narrative":"PF3D7_0307400 (PfClpP) is an apicoplast-localized serine protease that drives organellar proteostasis required for apicoplast biogenesis and blood-stage parasite survival in Plasmodium falciparum [PMID:20545854, PMID:29141210]. It assembles as homoheptameric rings that stack into a tetradecamer, and its crystal structure captures a compacted, catalytically inactive conformation resembling bacterial ClpPs [PMID:20887733]. The protease is synthesized as a zymogen that oligomerizes and matures through transautocatalytic processing, yielding a robustly active enzyme whose catalytic activity is essential for plastid biogenesis, as demonstrated by CRISPR/Cas9-expressed catalytically dead mutants [PMID:32482878]. PfClpP functions within a Clp proteolytic complex together with the PfClpC chaperone and the PfClpS substrate-adaptor; PfClpC chaperone activity is required to stabilize the mature protease, and both PfClpS and PfClpC are needed for apicoplast maintenance [PMID:29141210, PMID:32482878]. Unlike the situation in other organisms, PfClpP and the pseudo-protease PfClpR co-localize to the apicoplast but do not form a stable heterocomplex, with PfClpR forming a distinct open heptameric ring bearing an inactive catalytic triad [PMID:23192353]. Active-site β-lactone inhibitors and structure-based pyrimidine compounds inhibit PfClpP enzymatic activity, arrest parasite growth, and cause apicoplast developmental defects, establishing the protease as a validated antimalarial target [PMID:20545854, PMID:28917450].","teleology":[{"year":2010,"claim":"Establishing where PfClpP acts and whether it is enzymatically functional was the first step in defining its cellular role; localization and inhibitor experiments placed an active serine protease inside the apicoplast and tied its activity to organelle development.","evidence":"GFP-targeting, immunoelectron microscopy, immunofluorescence, and in vitro protease assay with an active-site β-lactone inhibitor in P. falciparum","pmids":["20545854"],"confidence":"High","gaps":["In vivo substrates not identified","Regulation of protease activity in the organelle not defined"],"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2010,"claim":"The oligomeric and structural basis of PfClpP function was resolved, showing it forms heptameric rings and a stacked tetradecamer, the canonical Clp protease architecture.","evidence":"Size-exclusion chromatography, analytical ultracentrifugation, electron microscopy, and X-ray crystallography of P. falciparum PfClpP","pmids":["20887733"],"confidence":"High","gaps":["Structure of the active-state assembly with partner chaperone not determined","Substrate-engaged conformation not captured"],"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2010,"claim":"Comparative structural analysis addressed how the ring toggles between activity states, proposing that the compact crystallographic form is an inactive state alternating with an extended active state.","evidence":"X-ray crystallography of a disulfide-linked E. coli ClpP mutant compared with PfClpP plus normal mode analysis","pmids":["20637416"],"confidence":"Medium","gaps":["Conformational switching not experimentally demonstrated in PfClpP itself","Trigger for the active/inactive transition unknown"],"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2012,"claim":"Whether PfClpP partners with the pseudo-protease PfClpR as in other systems was tested; the finding that no stable heterocomplex forms redefined the expected composition of the Plasmodium Clp complex.","evidence":"X-ray crystallography of PfClpR, biochemical interaction assays, and immunofluorescence localization in P. falciparum","pmids":["23192353"],"confidence":"Medium","gaps":["Functional role of PfClpR, if any, in relation to PfClpP unresolved","Single-lab negative result for the interaction"],"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2017,"claim":"The functional dependence of the protease on a chaperone was established, showing PfClpC is required to stabilize mature PfClpP and that inhibiting either causes the same apicoplast-loss phenotype rescuable by IPP.","evidence":"Double-conditional mutant parasite lines, IPP rescue assay, and Western blot for protein stability in P. falciparum","pmids":["29141210"],"confidence":"High","gaps":["Mechanism by which PfClpC stabilizes PfClpP not defined","Direct physical stoichiometry of the chaperone-protease assembly not resolved"],"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2017,"claim":"Structure-based screening extended the target-validation case, showing new pyrimidine inhibitors block PfClpP activity and impair apicoplast development in blood-stage parasites.","evidence":"In silico structure-based screening, in vitro enzymatic inhibition assay, and blood-stage growth/morphology analysis in P. falciparum","pmids":["28917450"],"confidence":"Medium","gaps":["Selectivity over host and other proteases not established in the timeline","In vivo efficacy not assessed"],"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":2020,"claim":"The catalytic requirement and complex composition were resolved together, showing PfClpP matures by transautocatalysis, its protease activity is essential for apicoplast biogenesis, and it operates with the PfClpS adaptor and PfClpC chaperone.","evidence":"Null and conditional mutants, CRISPR/Cas9-expressed catalytically dead mutant, and affinity purification/mass spectrometry in P. falciparum","pmids":["32482878"],"confidence":"High","gaps":["Physiological substrate repertoire only putatively identified","How PfClpS selects substrates for PfClpP degradation not mechanistically defined"],"attribution":[{"species":"Plasmodium falciparum","strain":""}]},{"year":null,"claim":"The in vivo substrate repertoire of PfClpP and the mechanism by which the PfClpC/PfClpS system delivers substrates to the proteolytic core remain to be defined.","evidence":"","pmids":[],"confidence":"Medium","gaps":["Bona fide degraded substrates not validated beyond affinity-purification candidates","Structural basis of the active PfClpP-PfClpC-PfClpS assembly unknown"],"attribution":[{"species":"Plasmodium falciparum","strain":""}]}],"mechanism_profile":{"molecular_activity":[],"localization":[],"pathway":[],"complexes":["Clp proteolytic complex (PfClpP with PfClpC chaperone and PfClpS substrate-adaptor) [#3, #4]","PfClpP homoheptameric ring / tetradecamer [#1]"],"partners":["PFCLPC CHAPERONE (STABILIZES MATURE PFCLPP) [#3, #4]","PFCLPS SUBSTRATE-ADAPTOR (INTERACTS WITH PFCLPP) [#4]","PFCLPR (CO-LOCALIZES BUT DOES NOT FORM A STABLE HETEROCOMPLEX WITH PFCLPP) [#5]"],"other_free_text":["Synthesized as a zymogen that oligomerizes and matures by transautocatalysis [#4]","Compact crystallographic conformation corresponds to an inactive state alternating with an extended active state [#2]","Inhibited by active-site β-lactone (U1-lactone) and by structure-based pyrimidine compounds, both causing apicoplast developmental defects [#0, #6]","Growth arrest and apicoplast loss upon inhibition are rescued by IPP supplementation [#3]"]}},"prefetch_data":{},"corpus_meta":[{"pmid":"20887733","id":"PMC_20887733","title":"The Clp chaperones and proteases of the human malaria parasite Plasmodium falciparum.","date":"2010","source":"Journal of molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/20887733","citation_count":71,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["PfClpP"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"33497624","id":"PMC_33497624","title":"Structure, function, and substrates of Clp AAA+ protease systems in cyanobacteria, plastids, and apicoplasts: A comparative analysis.","date":"2021","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/33497624","citation_count":61,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["ATP"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"20637416","id":"PMC_20637416","title":"Structural and theoretical studies indicate that the cylindrical protease ClpP samples extended and compact conformations.","date":"2010","source":"Structure (London, England : 1993)","url":"https://pubmed.ncbi.nlm.nih.gov/20637416","citation_count":53,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["ClpP"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"29141210","id":"PMC_29141210","title":"PfClpC Is an Essential Clp Chaperone Required for Plastid Integrity and Clp Protease Stability in Plasmodium falciparum.","date":"2017","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/29141210","citation_count":42,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["PfClpP"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"30009761","id":"PMC_30009761","title":"The proteasome as a target to combat malaria: hits and misses.","date":"2018","source":"Translational research : the journal of laboratory and clinical medicine","url":"https://pubmed.ncbi.nlm.nih.gov/30009761","citation_count":37,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["ClpP"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"20545854","id":"PMC_20545854","title":"A cyanobacterial serine protease of Plasmodium falciparum is targeted to the apicoplast and plays an important role in its growth and development.","date":"2010","source":"Molecular microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/20545854","citation_count":36,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["ClpP","ATP","PfClpP"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"32482878","id":"PMC_32482878","title":"Plastid biogenesis in malaria parasites requires the interactions and catalytic activity of the Clp proteolytic system.","date":"2020","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/32482878","citation_count":29,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["PfClpP"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"23192353","id":"PMC_23192353","title":"Structural insights into the inactive subunit of the apicoplast-localized caseinolytic protease complex of Plasmodium falciparum.","date":"2012","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/23192353","citation_count":23,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["ClpP","PfClpP"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"34882737","id":"PMC_34882737","title":"Microbial proteasomes as drug targets.","date":"2021","source":"PLoS pathogens","url":"https://pubmed.ncbi.nlm.nih.gov/34882737","citation_count":23,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["ATP"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false},{"pmid":"28917450","id":"PMC_28917450","title":"A novel class of Plasmodial ClpP protease inhibitors as potential antimalarial agents.","date":"2017","source":"Bioorganic & medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/28917450","citation_count":22,"is_preprint":false,"source_species":["Pf"],"role":"primary","match_terms":["ClpP","ATP"],"competing_organism_flag":false,"competing_organism_match":"","competing_organism_only":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":7119,"output_tokens":2057,"usd":0.026106,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":7296,"output_tokens":3565,"usd":0.062802,"stage2_stop_reason":"end_turn"},"total_usd":0.088908,"stage1_batch_id":"msgbatch_01DbiymDmubkPpYvdbAu5a7V","stage2_batch_id":"msgbatch_012TbrWvMRH129T7PQ4SmvrJ","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2010,\n      \"finding\": \"PfClpP (PF3D7_0307400) localizes to the apicoplast of P. falciparum, confirmed by GFP-targeting, immunoelectron microscopy, and immunofluorescence assays. It possesses serine protease activity demonstrated by an in vitro protease assay, and a specific β-lactone inhibitor (U1-lactone) that binds its active site inhibited parasite growth and caused apicoplast developmental defects.\",\n      \"method\": \"GFP-targeting, immunoelectron microscopy, immunofluorescence assay, in vitro protease assay with active-site β-lactone inhibitor\",\n      \"journal\": \"Molecular microbiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal localization methods plus in vitro enzymatic activity assay with a specific active-site inhibitor, functional consequence demonstrated\",\n      \"pmids\": [\"20545854\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"PfClpP (PF3D7_0307400) forms mostly homoheptameric rings as shown by size-exclusion chromatography, analytical ultracentrifugation, and electron microscopy. Its X-ray crystal structure reveals a compacted tetradecamer (two stacked heptameric rings) similar to Streptococcus pneumoniae and Mycobacterium tuberculosis ClpPs. The protein localizes to the apicoplast.\",\n      \"method\": \"Size-exclusion chromatography, analytical ultracentrifugation, electron microscopy, X-ray crystallography\",\n      \"journal\": \"Journal of molecular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — crystal structure determined plus multiple biophysical methods confirming oligomeric state, replicated across publications\",\n      \"pmids\": [\"20887733\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"The compact tetradecameric conformation of PfClpP observed by X-ray crystallography corresponds to an inactive state; structural and normal mode analysis support a model in which the ClpP cylinder switches dynamically between an active extended state (substrate degradation) and an inactive compact state (peptide product release).\",\n      \"method\": \"X-ray crystallography of disulfide-linked E. coli ClpP mutant compared with PfClpP structure; normal mode analysis\",\n      \"journal\": \"Structure\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Weak — crystal structures compared across species and computational modeling used; direct conformational switching not experimentally demonstrated in PfClpP itself\",\n      \"pmids\": [\"20637416\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Using a double-conditional mutant parasite line, PfClpC chaperone activity was shown to be required to stabilize the mature PfClpP (PF3D7_0307400) protease, revealing a functional chaperone-protease interaction. Conditional inhibition of PfClpP, like PfClpC, led to growth arrest and apicoplast loss rescued by IPP supplementation.\",\n      \"method\": \"Conditional mutant parasite lines (double-conditional mutant), IPP rescue assay, Western blot for protein stability\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic conditional mutants with orthogonal rescue experiment demonstrating functional interaction; single lab\",\n      \"pmids\": [\"29141210\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"PfClpP (PF3D7_0307400) has robust catalytic activity essential for apicoplast biogenesis. CRISPR/Cas9-expressed catalytically dead PfClpP showed it oligomerizes as a zymogen and is matured via transautocatalysis. Affinity purification screens identified the Clp complex composition and putative ClpP substrates, including an interaction with the PfClpS substrate-adaptor (shown to be essential for plastid biogenesis by conditional mutant) and PfClpC chaperone.\",\n      \"method\": \"Null and conditional mutants, CRISPR/Cas9-based catalytically dead mutant expression, affinity purification/mass spectrometry\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — catalytic dead mutant with reconstitution-level mutagenesis, CRISPR/Cas9, affinity purification, multiple orthogonal methods in one study\",\n      \"pmids\": [\"32482878\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Biochemical and structural data indicate that, contrary to what has been observed in other organisms, PfClpP (PF3D7_0307400) and PfClpR do NOT form a stable heterocomplex in the apicoplast of P. falciparum. PfClpR localizes to the apicoplast as does PfClpP, but forms a distinct open flat heptameric ring with an inactive catalytic triad.\",\n      \"method\": \"X-ray crystallography of PfClpR, biochemical interaction assays, localization by immunofluorescence\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — crystal structure plus biochemical interaction assays, single lab; the negative result (no stable heterocomplex) is directly relevant to PfClpP function\",\n      \"pmids\": [\"23192353\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Novel pyrimidine-series compounds identified by in silico structure-based screening inhibit PfClpP (PF3D7_0307400) protease activity in vitro and show antiparasitic activity in blood-stage P. falciparum, with treated parasites exhibiting morphological abnormalities and impaired apicoplast development.\",\n      \"method\": \"In silico structure-based screening, in vitro PfClpP enzymatic inhibition assay, blood-stage parasite growth assay, morphological analysis\",\n      \"journal\": \"Bioorganic & medicinal chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vitro enzymatic assay plus cellular phenotypic readout; structure-activity relationship established, single lab\",\n      \"pmids\": [\"28917450\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Plasmodium falciparum\", \"strain\": \"\"}]\n    }\n  ],\n  \"current_model\": \"PF3D7_0307400 (PfClpP) is an apicoplast-localized serine protease that assembles as a homoheptameric ring (and tetradecamer) via transautocatalytic zymogen maturation, requires the PfClpC chaperone for its stability and activity, participates in a Clp proteolytic complex with PfClpC and the substrate-adaptor PfClpS (but does not form a stable heterocomplex with PfClpR), and is essential for apicoplast biogenesis and parasite survival.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"PF3D7_0307400 (PfClpP) is an apicoplast-localized serine protease that drives organellar proteostasis required for apicoplast biogenesis and blood-stage parasite survival in Plasmodium falciparum [#0, #3]. It assembles as homoheptameric rings that stack into a tetradecamer, and its crystal structure captures a compacted, catalytically inactive conformation resembling bacterial ClpPs [#1]. The protease is synthesized as a zymogen that oligomerizes and matures through transautocatalytic processing, yielding a robustly active enzyme whose catalytic activity is essential for plastid biogenesis, as demonstrated by CRISPR/Cas9-expressed catalytically dead mutants [#4]. PfClpP functions within a Clp proteolytic complex together with the PfClpC chaperone and the PfClpS substrate-adaptor; PfClpC chaperone activity is required to stabilize the mature protease, and both PfClpS and PfClpC are needed for apicoplast maintenance [#3, #4]. Unlike the situation in other organisms, PfClpP and the pseudo-protease PfClpR co-localize to the apicoplast but do not form a stable heterocomplex, with PfClpR forming a distinct open heptameric ring bearing an inactive catalytic triad [#5]. Active-site \\u03b2-lactone inhibitors and structure-based pyrimidine compounds inhibit PfClpP enzymatic activity, arrest parasite growth, and cause apicoplast developmental defects, establishing the protease as a validated antimalarial target [#0, #6].\",\n  \"teleology\": [\n    {\n      \"year\": 2010,\n      \"claim\": \"Establishing where PfClpP acts and whether it is enzymatically functional was the first step in defining its cellular role; localization and inhibitor experiments placed an active serine protease inside the apicoplast and tied its activity to organelle development.\",\n      \"evidence\": \"GFP-targeting, immunoelectron microscopy, immunofluorescence, and in vitro protease assay with an active-site \\u03b2-lactone inhibitor in P. falciparum\",\n      \"pmids\": [\n        \"20545854\"\n      ],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"In vivo substrates not identified\",\n        \"Regulation of protease activity in the organelle not defined\"\n      ],\n      \"attribution\": [\n        {\n          \"species\": \"Plasmodium falciparum\",\n          \"strain\": \"\"\n        }\n      ]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"The oligomeric and structural basis of PfClpP function was resolved, showing it forms heptameric rings and a stacked tetradecamer, the canonical Clp protease architecture.\",\n      \"evidence\": \"Size-exclusion chromatography, analytical ultracentrifugation, electron microscopy, and X-ray crystallography of P. falciparum PfClpP\",\n      \"pmids\": [\n        \"20887733\"\n      ],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Structure of the active-state assembly with partner chaperone not determined\",\n        \"Substrate-engaged conformation not captured\"\n      ],\n      \"attribution\": [\n        {\n          \"species\": \"Plasmodium falciparum\",\n          \"strain\": \"\"\n        }\n      ]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Comparative structural analysis addressed how the ring toggles between activity states, proposing that the compact crystallographic form is an inactive state alternating with an extended active state.\",\n      \"evidence\": \"X-ray crystallography of a disulfide-linked E. coli ClpP mutant compared with PfClpP plus normal mode analysis\",\n      \"pmids\": [\n        \"20637416\"\n      ],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Conformational switching not experimentally demonstrated in PfClpP itself\",\n        \"Trigger for the active/inactive transition unknown\"\n      ],\n      \"attribution\": [\n        {\n          \"species\": \"Plasmodium falciparum\",\n          \"strain\": \"\"\n        }\n      ]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Whether PfClpP partners with the pseudo-protease PfClpR as in other systems was tested; the finding that no stable heterocomplex forms redefined the expected composition of the Plasmodium Clp complex.\",\n      \"evidence\": \"X-ray crystallography of PfClpR, biochemical interaction assays, and immunofluorescence localization in P. falciparum\",\n      \"pmids\": [\n        \"23192353\"\n      ],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Functional role of PfClpR, if any, in relation to PfClpP unresolved\",\n        \"Single-lab negative result for the interaction\"\n      ],\n      \"attribution\": [\n        {\n          \"species\": \"Plasmodium falciparum\",\n          \"strain\": \"\"\n        }\n      ]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"The functional dependence of the protease on a chaperone was established, showing PfClpC is required to stabilize mature PfClpP and that inhibiting either causes the same apicoplast-loss phenotype rescuable by IPP.\",\n      \"evidence\": \"Double-conditional mutant parasite lines, IPP rescue assay, and Western blot for protein stability in P. falciparum\",\n      \"pmids\": [\n        \"29141210\"\n      ],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Mechanism by which PfClpC stabilizes PfClpP not defined\",\n        \"Direct physical stoichiometry of the chaperone-protease assembly not resolved\"\n      ],\n      \"attribution\": [\n        {\n          \"species\": \"Plasmodium falciparum\",\n          \"strain\": \"\"\n        }\n      ]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Structure-based screening extended the target-validation case, showing new pyrimidine inhibitors block PfClpP activity and impair apicoplast development in blood-stage parasites.\",\n      \"evidence\": \"In silico structure-based screening, in vitro enzymatic inhibition assay, and blood-stage growth/morphology analysis in P. falciparum\",\n      \"pmids\": [\n        \"28917450\"\n      ],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Selectivity over host and other proteases not established in the timeline\",\n        \"In vivo efficacy not assessed\"\n      ],\n      \"attribution\": [\n        {\n          \"species\": \"Plasmodium falciparum\",\n          \"strain\": \"\"\n        }\n      ]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"The catalytic requirement and complex composition were resolved together, showing PfClpP matures by transautocatalysis, its protease activity is essential for apicoplast biogenesis, and it operates with the PfClpS adaptor and PfClpC chaperone.\",\n      \"evidence\": \"Null and conditional mutants, CRISPR/Cas9-expressed catalytically dead mutant, and affinity purification/mass spectrometry in P. falciparum\",\n      \"pmids\": [\n        \"32482878\"\n      ],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Physiological substrate repertoire only putatively identified\",\n        \"How PfClpS selects substrates for PfClpP degradation not mechanistically defined\"\n      ],\n      \"attribution\": [\n        {\n          \"species\": \"Plasmodium falciparum\",\n          \"strain\": \"\"\n        }\n      ]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"The in vivo substrate repertoire of PfClpP and the mechanism by which the PfClpC/PfClpS system delivers substrates to the proteolytic core remain to be defined.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Bona fide degraded substrates not validated beyond affinity-purification candidates\",\n        \"Structural basis of the active PfClpP-PfClpC-PfClpS assembly unknown\"\n      ],\n      \"attribution\": [\n        {\n          \"species\": \"Plasmodium falciparum\",\n          \"strain\": \"\"\n        }\n      ]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\n        \"term_id\": \"GO:0004252\",\n        \"supporting_discovery_ids\": [\n          0,\n          4,\n          6\n        ]\n      },\n      {\n        \"term_id\": \"GO:0016787\",\n        \"supporting_discovery_ids\": [\n          0,\n          4\n        ]\n      },\n      {\n        \"term_id\": \"GO:0042803\",\n        \"supporting_discovery_ids\": [\n          1\n        ]\n      }\n    ],\n    \"localization\": [\n      {\n        \"term_id\": \"GO:0009507\",\n        \"supporting_discovery_ids\": [\n          0,\n          1,\n          5\n        ]\n      },\n      {\n        \"term_id\": \"GO:0020011\",\n        \"supporting_discovery_ids\": [\n          0,\n          1\n        ]\n      }\n    ],\n    \"pathway\": [\n      {\n        \"term_id\": \"GO:0006508\",\n        \"supporting_discovery_ids\": [\n          0,\n          4\n        ]\n      },\n      {\n        \"term_id\": \"GO:0010287\",\n        \"supporting_discovery_ids\": [\n          3,\n          4,\n          6\n        ]\n      }\n    ],\n    \"complexes\": [\n      \"Clp proteolytic complex (PfClpP with PfClpC chaperone and PfClpS substrate-adaptor) [#3, #4]\",\n      \"PfClpP homoheptameric ring / tetradecamer [#1]\"\n    ],\n    \"partners\": [\n      \"PfClpC chaperone (stabilizes mature PfClpP) [#3, #4]\",\n      \"PfClpS substrate-adaptor (interacts with PfClpP) [#4]\",\n      \"PfClpR (co-localizes but does NOT form a stable heterocomplex with PfClpP) [#5]\"\n    ],\n    \"other_free_text\": [\n      \"Synthesized as a zymogen that oligomerizes and matures by transautocatalysis [#4]\",\n      \"Compact crystallographic conformation corresponds to an inactive state alternating with an extended active state [#2]\",\n      \"Inhibited by active-site \\u03b2-lactone (U1-lactone) and by structure-based pyrimidine compounds, both causing apicoplast developmental defects [#0, #6]\",\n      \"Growth arrest and apicoplast loss upon inhibition are rescued by IPP supplementation [#3]\"\n    ]\n  }\n}","audit_flag":null,"strains":[{"strain":"Pf3D7","gene_id":"PF3D7_0307400","name":null,"product":"ATP-dependent Clp protease proteolytic subunit","uniprot_acc":null,"chromosome":null,"start_pos":null},{"strain":"PbANKA","gene_id":"PBANKA_0405700","name":null,"product":"ATP-dependent Clp protease proteolytic subunit, putative","uniprot_acc":null,"chromosome":null,"start_pos":null},{"strain":"PkH","gene_id":"PKNH_0835300","name":null,"product":"ATP-dependent Clp protease proteolytic subunit, putative","uniprot_acc":null,"chromosome":null,"start_pos":null}],"gene_symbol":"ClpP","evaluation":null}